MindWalk Holdings (HYFT) EBT (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly EBT of -$2828.3 for Q2 2026, up 76.48% year-over-year from -$1602.6 in Q2 2025, and up 81.35% quarter-over-quarter from -$15168.0 in Q1 2026.
MindWalk Holdings (HYFT) EBT (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported EBT for 7 consecutive years, with -$2828.3 the latest figure, recorded in Q2 2026.
- In Q2 2026, EBT rose 76.48% year-over-year to -$2828.3; the TTM figure through Apr 2026 stood at $2.1 billion (down 17.72% YoY), while the FY2026 annual figure was -$11.3 million, up 58.0% from the prior year.
- EBT climbed to -$2828.3 in Q2 2026 per HYFT's latest filing, from -$15168.0 in the prior quarter.
- Across five years, EBT topped out at $3.4 billion in Q3 2023 and bottomed at -$33.5 million in Q2 2023.
- Historically, EBT has averaged $525.7 million across 5 years, with a median of $1.2 million in 2023.
- Annual changes were most pronounced in 2022 — EBT sank 424.73% — and 2023, when it jumped 39321542.99%.
- MindWalk Holdings' EBT stood at $4.0 million in 2022, then jumped by 35534.74% to $1.4 billion in 2023, then plunged by 99.88% to $1.7 million in 2024, then grew by 29.05% to $2.3 million in 2025, then sank by 100.13% to -$2828.3 in 2026.
- Business Quant data shows HYFT's EBT at -$2828.3 in Q2 2026, -$15168.0 in Q1 2026, and $2.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -294.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -2,828.29 |
| Jan 31, 2026 | -15,167.99 |
| Oct 31, 2025 | 2.25 Mn |
| Jul 31, 2025 | 2.10 Bn |
| Apr 30, 2025 | -12,025.80 |
| Jan 31, 2025 | 14.83 Mn |
| Oct 31, 2024 | 1.75 Mn |
| Jul 31, 2024 | 2.54 Bn |
| Apr 30, 2024 | -30.81 Mn |
| Jan 31, 2024 | 2.28 Mn |
| Oct 31, 2023 | 1.44 Bn |
| Jul 31, 2023 | 3.44 Bn |
| Apr 30, 2023 | -33.47 Mn |
| Jan 31, 2023 | 705,066.09 |
| Oct 31, 2022 | 4.03 Mn |
| Jul 31, 2022 | -8,737.85 |
| Apr 30, 2022 | -14.60 Mn |
| Jan 31, 2022 | -3,073.42 |
| Oct 31, 2021 | -4,477.52 |
| Jul 31, 2021 | -2,721.96 |